Medical Properties Trust (NYSE:MPW) Lowered to “Neutral” at BNP Paribas

Medical Properties Trust (NYSE:MPW) was downgraded by BNP Paribas from an “outperform” rating to a “neutral” rating in a note issued to investors on Tuesday, FinViz reports. They presently have a $4.00 price objective on the real estate investment trust’s stock. BNP Paribas’ price objective indicates a potential downside of 2.32% from the stock’s previous close.

MPW has been the subject of several other reports. StockNews.com lowered Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Saturday, May 18th. Deutsche Bank Aktiengesellschaft raised Medical Properties Trust from a “sell” rating to a “hold” rating and boosted their price objective for the company from $2.00 to $5.00 in a research note on Wednesday, April 17th. Colliers Securities lowered Medical Properties Trust from a “buy” rating to a “neutral” rating and cut their target price for the company from $10.00 to $4.25 in a research report on Wednesday, April 10th. Royal Bank of Canada restated a “sector perform” rating and set a $5.00 target price on shares of Medical Properties Trust in a research report on Tuesday, May 14th. Finally, Truist Financial upped their target price on Medical Properties Trust from $4.50 to $5.00 and gave the company a “hold” rating in a research report on Thursday, May 30th. Five analysts have rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $5.61.

Medical Properties Trust Stock Down 5.0 %

Shares of NYSE:MPW opened at $4.10 on Tuesday. The firm has a market cap of $2.46 billion, a P/E ratio of -1.84, a P/E/G ratio of 0.62 and a beta of 1.27. The company has a quick ratio of 3.10, a current ratio of 3.10 and a debt-to-equity ratio of 1.51. Medical Properties Trust has a 12-month low of $2.92 and a 12-month high of $10.74. The business has a fifty day simple moving average of $4.92 and a 200 day simple moving average of $4.37.

Institutional Trading of Medical Properties Trust

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Alpine Global Management LLC purchased a new stake in shares of Medical Properties Trust during the third quarter valued at approximately $273,000. AQR Capital Management LLC increased its position in shares of Medical Properties Trust by 125.3% during the third quarter. AQR Capital Management LLC now owns 2,261,451 shares of the real estate investment trust’s stock valued at $12,325,000 after acquiring an additional 1,257,921 shares during the last quarter. Legal & General Group Plc increased its position in shares of Medical Properties Trust by 0.3% during the third quarter. Legal & General Group Plc now owns 4,852,620 shares of the real estate investment trust’s stock valued at $26,447,000 after acquiring an additional 13,585 shares during the last quarter. KPP Advisory Services LLC purchased a new stake in shares of Medical Properties Trust during the third quarter valued at approximately $172,000. Finally, Penserra Capital Management LLC grew its holdings in Medical Properties Trust by 14.4% during the third quarter. Penserra Capital Management LLC now owns 74,367 shares of the real estate investment trust’s stock valued at $405,000 after purchasing an additional 9,381 shares during the period. 71.79% of the stock is owned by institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.